OOIR: Observatory of International Research

Papers

(The median citation count of International Journal of Gynecological Cancer is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Role of pre-diagnostic reproductive factors on long-term (10 years or greater) survival of epithelial ovarian cancer: The Extreme study	297
Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy	139
Growing teratoma syndrome	133
Inguinofemoral lymphadenectomy technique in 10 steps	102
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization	99
The Cukurova score in the prediction of primary cytoreduction in ovarian cancer	72
Three-dimensional image of uterine transposition	67
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico	65
Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery	64
Correction: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer	56
Management of stage III and IVa uterine cancer	55
Well-differentiated papillary mesothelial tumor of the peritoneum	52
Complementary use of indocyanine green and technetium to enhance sentinel lymphadenectomy in vulvar cancer	46
A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma	44
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeins	44
Surgical technique and surgeon volume: the pursuit of data-driven outcomes	43
Improvement in radiation techniques for locally advanced cervical cancer during the last two decades	42
Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement – OSAMA Study)	42
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology Registry	42
Surgical staging for locally-advanced cervical cancer: the answer remains ‘NO’	42
Computed tomography–based prediction of interval cytoreduction in advanced ovarian cancer	42
Authors’ response to: “Methodological concerns regarding AGO score validation in low-grade ovarian cancers”	41
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy	40
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma	39
22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report	39

Evaluating the use of machine learning in endometrial cancer: a systematic review	38
A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets	37
Utilization of artificial intelligence to mitigate health inequalities in gynecological cancer care	36
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation	34
Response to the letter regarding the article "Predictive factors for adnexal involvement in endometrial cancer FIGO stage IIIA"	34
PARSGO and UM6SS: spearheading excellence in gynecological oncology in Morocco	34
Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies	34
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study	33
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)	32
Use of social media for academic and professional purposes by gynecologic oncologists	32
Correspondence on “Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysis” by Zhu and colleagues	31
Erratum to ‘Controversies in vulvar cancer: revisiting the margin of error’ [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101678]	31
Correspondence on ‘Enhanced recovery after surgery in gynecologic oncology: time to address barriers to implementation in low- and middle-income countries’ by Nelson et al	30
Pocket guide based on the TNM and FIGO staging systems for classifying patients with locally advanced cervical cancer: a practical tool from the GINECO group for quick and easy management	30
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024	29
Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation	29
Patient-initiated follow-up in low-risk endometrial cancer after surgery: a systematic review	29
Sarcopenia shortens overall survival of patients with platinum-resistant recurrent ovarian cancer: inverse probability of treatment-weighting analysis	28
The Silva Pattern-Based Classification And Oncological Outcomes In Women Undergoing Fertility-Sparing Surgery For Early-Stage Cervical Cancer	27
Controversies in the management of mucinous ovarian tumors	26
Does The Origin Of Ovarian Cancer Influence Outcomes?	25
Does Sentinel Node Know The Cancer Origin? Comparing Sentinel Lymph Nodes Localization In Endometrial And Cervical Cancer	25
Surgical Release Of The Pudendal Nerve By Robotic Approach In 10 Steps	25
Advanced Techniques In Pelvic Exenteration For Cervical Cancer: A Case-Based Surgical Guide	25
PROGNOSTIC FACTORS BASED ON THE MOLECULAR CLASSIFICATION OF ENDOMETRIAL CANCER: SINGLE INSTITUTION STUDY	25
Surgical Treatment Of Advanced Ovarian Cancer: Experience From A Brazilian Cancer Center (Barretos Cancer Hospital) In 2023	24
Secondary Debulking Followed By Localised Radiotherapy In Patients With Oligometastatic Recurrent Ovarian Cancer – A Case Series Of Two International Cancer Centres	24
Prognostic Factors In Adult Granulosa Cell Tumours Of The Ovary And Long Term Follow-Up. (The Norwegian Radium Hospital Experience 1971-2024)	24
The “N-PLUS/NOGGO-Ov53/ENGOT-Ov62-STUDY” To De-Escalate Chemotherapy In Ovarian Cancer: Comparing 3 Vs. 6 Cycles Of Platinum-Based Chemotherapy After Complete Tumor Resection Followed By Niraparib Mai	24
The Prognostic And Predictive Value Of Cardiophrenic Lymph Nodes In Patients Receiving Hyperthermic Intraperitoneal Chemotherapy For Ovarian Cancer In The OVHIPEC-1 Trial	23
To Compare The Colposcopic Findings By International Federation Of Colposcopy And Cervical Pathology (IFCPC ) Nomenclature And Swede Score For Assessment Of High Grade Cervical Lesions	23
Impact Of Ascites And Peritoneal Metastatic Lesion Volumes, Measured By Newly Developed Deep Learning-Based Algorithm, In Advanced Epithelial Ovarian Cancer	23
A Multivariable Prognostic Analysis For Survival Outcomes In Women With Epithelial Ovarian Cancer - A North Indian Single Centre Study	23
A Young Woman Presenting Virilization With Ovarian Mass: A Case Report Of Rare Disease - Ovarian Steroid Tumor	22
Squamous Cell Carcinoma Arising In Mature Cystic Teratomas: A Case Series Review Of Presentation, Treatment, And Prognosis	22
The Role Of Second-Look Surgery In Recurrent Ovarian Cancer Based On The Type Of Relapse	22
The Role Of Prehabilitation In ERAS For Gynecologic Oncology In Germany	22
Prospective Multicentre Evaluation Of Secondary Cytoreductive Surgery In The Era Of PARP-Inhibitors (CONCEPT) In Relapsed Epithelial Ovarian Cancer	22
Early-Stage Breast Cancer: A Detailed Examination Of Clinicopathological Features	21
Excision Of Retroperitoneal Mass - Laparoscopic Management Of Iliac Artery Injury	21
Impact Of Surgery On Survival Outcomes In Locally Advanced Cervical Cancer Patients With Partial Response After Primary Chemoradiotherapy	21
Evaluating The Implementation And Outcomes Of The Tumor-First Testing Strategy For BRCA1/2 Pathogenic Variants In Ovarian Cancer Patients: A Center-Wide Analysis	21
SPLEEN PRESERVING EXTENSIVE CYTOREDUCTIVE SURGERY	21
Hepatic hilum cytoreductive surgery for ovarian cancer relapse☆	21
Survival Prediction And Mortality Risk Stratification In Ovarian Cancer After NACT: PRGS Outperforms CRS Regression Scoring	21
Trop-2 Expression In Cervical Carcinoma (CX) - A Possible Target For The Antibody Drug Conjugate Sacituzumab	21
Comparative Outcomes Of Excision And Active Surveillance For Cervical Intraepithelial Neoplasia 2 In Women Under 35	21
Perioperative Outcomes Of Heated Intraperitoneal Chemotherapy For Patients Enrolled In The Feasibility Phase Of A Randomized Controlled Trial: Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy	20
Histological Findings After Completion Hysterectomy And Clinical Outcome Following Conservative Treatment Of Endometrial Carcinoma	20
Assessment Of The Predictive Role Of Khorana Score And Genomic Profiling In Ovarian Cancer-Related Venous Thromboembolism	20

Impact Of Preoperative Conization On The Prognosis Of Cervical Cancer Patients Undergoing Open Abdominal Radical Hysterectomy	20
Homologous Recombination Deficiency (HRD) In P53 Abnormal Endometrial Carcinoma	20
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer	19
Clinical Significance Of Low Volume Lymph Node Metastasis In Early Stage Cervical Cancer: A Single Centre Case Series	19
Overall survival after surgical staging by lymph node dissection versus sentinel lymph node biopsy in endometrial cancer: a national cancer database study	19
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research a	18
Management of intravenous leiomyomatosis: a comprehensive review of surgical and perioperative considerations	18
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer	18
Safety and management of niraparib monotherapy in ovarian cancer clinical trials	18
ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer	18
Use of quadratus lumborum block in gynecologic procedures	18
Preoperative PET Scan Is Associated With Lower Rates Of Adjuvant Treatment In Surgically Treated Cervical Cancer Patients: A 4C Working Group Study	17
Robot-assisted utero-ovarian transposition and reanastomosis in vaginal cancer: a step-by-step description technique	17
Urinary Complications Of Bricker Procedures In Oncogynecology: A Monocentric Retrospective Analysis Of 77 Cases Over 20 Years	17
Deep Dive Into No Specific Molecular Profile (NSMP) Endometrial Cancer: Unraveling Genomic Features According To Estrogen Receptor (ER) Expression	17
Vulvar cancer resection with V–Y advancement flap reconstruction	17
Survival After Incidental Cervical Cancer Diagnosis Following Simple Hysterectomy Compared To Planned Oncological Management In Tumors ≤2 Cm	17
ARE ALL MISMATCH REPAIR DEFICIENT ENDOMETRIAL CANCERS CREATED EQUAL? A LARGE, RETROSPECTIVE, TERTIARY CENTER EXPERIENCE.	17
Topographic Distribution Of Histologically Confirmed Pelvic And Aortic Lymph Node Metastasis In Stage IIIC1r Locally Advanced Cervical Cancer: A Spain-GOG Retrospective Study.	17
Performance of molecular classification in predicting oncologic outcomes of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer	17
Abnormal Uterine Bleeding As A Predictor Of Endometrial Hyperplasia And Cancer Pathology In Postmenopausal Tamoxifen Treated Breast Cancer Patients	17
Brenner'S Tumors: An Update	16
Evaluation Of The MIDKINE Cytokine In Serum, Tumour Tissues And Lymph Nodes Of Patients With Endometrial Cancer	16
Technical And Organizational Solutions For Research Endometrial Cancer Data Collection: The Ambispective, Multicentric ENDOCancer-DATA	16
Impact Of Patient Characteristics On Primary Treatment Approach; A Population Based Study Regarding Incidence, Management And Outcome Of Endometrial Cancer Patients In The Netherlands Over 1995-2022	16
CDK7 Inhibition By THZ1 Triggers Pyroptosis And Enhances Immune Response In Ovarian Cancer	16
Evaluating Surgical Efficiency In Robotic-Assisted Hysterectomies For Endometrial Cancer And Benign Gynecologic Conditions	16
Exceptional Survival And Carcinomatous Recurrence In Mixed Papillary Adenocarcinoma Of The Fallopian Tube: A Clinical Case Report	16
The Role Of Completion Surgery After Menopause In Women With Borderline Ovarian Tumors Treated With Fertility Sparing Surgery - A Multicenter Retrospective Cohort Study	16
Obesity In Endometrial Cancer - A Patient Treated With Curative Radiotherapy Using A Custom-Made 3D-Printed Applicator	16
Comparative Efficacy Analysis Between Adjuvant Vaginal Cuff Brachytherapy And Pelvic External Beam Radiation Treatment For Women With FIGO Stage I Uterine Endometrioid Carcinoma With Pathologic Negati	16
Solitary Splenic Metastasis In Endometrial Cancer - A Systematic Review And Case Presentation	16
Minimally Invasive Surgery In Early-Stage Ovarian Cancer: Recurrence Analysis	15
Comparison Of VNOTES And Laparoscopic Surgery In Patients With Ascites	15
CLINICAL CHARACTERISTICS AND PROGNOSIS OF CLEAR CELL OVARIAN CARCINOMA IN A HOSPITAL IN PERU	15
Primary Ovarian Malignant Melanoma: A Case Report	15
Impact Of The COVID-19 Pandemic On Ovarian Cancer Diagnosis, Treatment, And Outcomes: A Systematic Review And Meta-Analysis	15
Therapeutic Resistance In Synchronous Endometrioid Carcinomas: A Case Report With A Pathogenic Germline Mutation In PMS2	15
Evaluation Of Clitoral Artery Doppler Parameters After Brachytherapy And Its Effects On Sexual Functions	15
MANAGEMENT OF A WOMAN WITH CERVICAL MELANOMA: A CASE REPORT AND LITERATURE REVIEW	15
The Impact Of BRCA Status On The Efficacy Of Paclitaxel Monotherapy In Recurrent Ovarian Cancer	15
Journal Information	15
12-Year Overall Survival And Prognostic Factors In Patients With FIGO Stage IA-IVA Vulvar Cancer Undergoing Surgery ± Adjuvant Radiation Therapy. Results From A Single Eastern European Center.	15
GENE EXPRESSION BASED STUDY TO IDENTIFY POOR PROGNOSTIC INDICATORS IN CARCINOMA CERVIX	15
Long Term Outcomes In Patients Treated By Extensive Bowel Resection Due To Advanced Ovarian Cancer	14
Assessing The Implications Of Sentinel Lymph Node Removal In Cervical Cancer: An Immunogenetic Perspective – A SENTICOL/GINECO Ancillary Study	14
Treatment Strategies In Advanced Ovarian Cancer: Primary Cytoreductive Surgery And Adjuvant Chemotherapy Versus Neoadjuvant Chemotherapy And Interval Cytoreduction - A Single-Center Retrospective Obse	14
ANTERIOR EXENTERATION FOR MULTIFOCAL VAGINAL CARCINOMA	14
Serous-Borderline Ovarian Tumors With Micropapillary Pattern Variants With Microinvasion Mimicking Advanced Stage Ovarian Carcinoma : A Rare Case Report	14
Are We Facing A Paradigm Shift In The Treatment Of Advanced Ovarian Cancer? Neoadjuvant Therapy Vs Primary Surgery	14
The Impact Of Hyperthermia On Cisplatin Cytotoxicity In Ovarian Cancer Cells	14
Squamous Cell Carcinoma Arising From A Mature Cystic Teratoma: A Rare Case	14
Glyoxalase 1: A Promising Biomarker And Target For Cervical Cancer Treatment	14
Exploring The Correlation Of Early Sexual Debut On Cervical HPV Infection In LMICs: Insights Through The Lens Of Sustainable Development Goals	14
Pelvic chondrosarcoma presenting as an adnexal mass treated with pubic bone resection	13
Incidence And Impact Of Low Volume Lymph Node Metastasis In Apparent Early-Stage Ovarian Cancer – MICR-OVARY Study.	13
Survival outcomes in patients with recurrent mixed sex cord-stromal tumors of the ovary	13
Risk factors for lymphedema and method of assessment in endometrial cancer: a prospective longitudinal multicenter study	13
Is It Time To Revise Cervical Cancer Screening Guidelines?	13
Addition of metronidazole to standard-of-care perioperative prophylaxis at the time of hysterectomy for gynecologic malignancies	13
Fertility-sparing treatment in early-stage cervical adenocarcinoma: assessing feasibility and limitations	13
Parental Knowledge And Health Beliefs Of HPV Vaccination In Kuwait: A Cross-Sectional Descriptive Survey	13
Improving Postoperative Outcomes By Implementing A Gynaecological Oncology-Specific ERAS Pathway In A UK Gynaecological Cancer Centre.	13
Oncological outcomes after laparotomic, laparoscopic, and robot-assisted laparoscopic staging for early high–intermediate or high-risk endometrial cancer	12
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer	12
Long-term impact of surgical route and tumor size on risk of recurrence among early-stage cervical cancer patients in a managed care population	12
Opioid and benzodiazepine use in gynecologic oncology patients	12
The benefit of sentinel lymph node evaluation in pre-operative grade 1 endometrial cancer	12
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions	12
Simple perinephric adipose tissue measurement for prediction of failed sentinel lymph node mapping in endometrial cancer	12
Mirvetuximab soravtansine shines post-PARP inhibitor progression: promising insights from the PICCOLO trial	12
Can the Tilburg Frailty Indicator predict post-operative quality of recovery in patients with gynecologic cancer? A prospective cohort study	12
Rising endometrial cancer rates and potential for screening	11
Peritoneal cancer index: laparoscopic evaluation of peritoneal carcinomatosis from gynecological origin	11
Rare intra-tumoral colonization of Fusobacterium nucleatum in endometrial cancer	11
HPV mRNA testing in cervical cancer screening: implications for low- and middle-income countries	11
Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer	11
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc’s Scholar Career Development Award and New Investigator Program	11
Correspondence on ‘Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer’ by Luzarraga Aznar et al	11
Correspondence on “Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods” by Navarro Santana et al	11

Some thoughts about surgery in ovarian cancer 2021	11
Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer	11
RETRACTED: Role of lymphadenectomy in advanced ovarian cancer—a subgroup analysis of the patients excluded from the LION trial (the Charité cohort)	11
The Role Of Vaginal Microbiota And HPV DNA Methylation In Cervical Lesion Progression	11
Clinical and pathological overview of endometrial endometrioid carcinoma	11
Response to: Correspondence on 'Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer' by Zhang and Sun	11
Advanced metastatic G1 endometrioid endometrial carcinoma (no specific molecular profile group)	11
First workshop on cervix cancer surgery in Latin America: a hands-on experience from Lima, Perú	11
Exploring global barriers to optimal ovarian cancer care: thematic analysis	11
Correspondence on “Use and Outcomes of Hormonal Therapy for Advanced Stage, Low-Grade Serous Ovarian Cancer” by Yoh et al	11
Bilateral oophorectomy and the probability of amnestic mild cognitive impairment among carriers of a pathogenic variant in BRCA1 or BRCA2	10
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare	10
Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation	10
Serous endometrial intra-epithelial carcinoma: an observational study	10
Advanced ovarian yolk sac tumor: upfront surgery or neoadjuvant chemotherapy followed by interval debulking?	10
Huge cystic renal cell carcinoma misdiagnosed as ovarian cancer	10
Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy	10
Locally advanced vulvar carcinoma diagnosed during cervical cancer screening	10
Analysis of the global burden of ovarian cancer in adolescents	10
Correspondence on ‘Cardiophrenic and costophrenic lymphadenectomy in advanced ovarian cancer by prediaphragmatic subxiphoid approach: PS technique’ by Stanciu	10
Treatment tolerability associated with carboplatin dose based on actual versus adjusted body weight in patients with a body mass index ≥25 kg/m2 with advanced ovarian cancer	10
Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer	10
Fertility-sparing approach for uterine smooth muscle tumors of uncertain malignant potential	10
Secondary cytoreduction in platinum sensitive relapsed ovarian cancer: an individual patient level meta-analysis	10
Body composition as a predictive factor for chemotherapy-induced peripheral neuropathy and dose-limiting toxicity in patients with endometrial cancer undergoing carboplatin and paclitaxel	10
Correction: Oncologic outcomes of uterine preservation for pre-menopausal patients with stage II epithelial ovarian carcinoma	10
Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study	10
The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvant chemotherapy	10
Proof-of-concept randomized phase II non-inferiority trial of simple versus type B2 hysterectomy in early-stage cervical cancer ≤2 cm (LESSER)	10
Tailoring treatment for advanced and/or recurrent ovarian cancer using the response of circulating tumor cells to therapy: A retrospective analysis	10
Correspondence on ‘Sentinel lymph node assessment in patients with atypical endometrial hyperplasia: a systematic review and meta-analysis’ by Vieira-Serna et al	10
Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines	10
The tug of war: delivering safe gynecologic oncology treatment amid insecurity in Haiti	10
Correspondence on 'ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*'	10
Outcomes of open radical hysterectomy following implementation of an enhanced recovery after surgery program	10
Diagnostic and treatment considerations for synchronous cancer of the ovary and endometrium	10
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy	9
Comparison Of Microsatellite Instability Detection By Immunohistochemistry And Molecular Technique In Endometrial Cancer	9
ENDOESTRO-Score: Where Is The Dark Side? Evaluation Of Estrogen Receptor Expression Cut-Off In Endometrial Cancer Molecular Classification, A Retrospective Study	9
Complete Resection After Interval Cytoreductive Surgery For Advanced Ovarian Cancer Subjected To Neoadjuvant Chemotherapy: A Systematic Review And Meta-Analysis Of Diagnostic Test Accuracy	9
Prospective Assessment Of The Association Between Perioperative Fluid Balance And Postoperative Complications After Surgery For Advanced Ovarian Cancer; Ancillary Data From A Randomised Controlled Tri	9
Copy number variations in endometrial cancer: from biological significance to clinical utility	9
Controversies in the Management of Mesonephric and Mesonephric-Like Adenocarcinomas of the Female Genital Tract	9
Tunisian Women’s Perception And Knowledge Of Cervical Cancer Screening: Are We Aware Yet?	9
Patients With Endometrial Cancer: Exploring Comorbidities And Quality Of Life – First Results Of An International Survey (NOGGO, ENGOT, GCIG - IMPROVE/EXPRESSION XI)	9
Cost impact analysis of enhanced recovery after minimally invasive gynecologic oncology surgery	9
Uterine transposition for fertility and ovarian function preservation after radiotherapy	9
Obstetric And Oncology Outcomes Following Fertility-Sparing Surgery In Non-Epithelial Ovarian Cancer, Epithelial Ovarian Cancer And Borderline Ovarian Tumors: A Systematic Review And Meta-Analysis	9
Anterior Exenteration And Bricker Urinary Diversion For Cervical Cancer Recurrence	9
Obstetric Outcome Following Conservative Treatment Of Endometrial Carcinoma	9
Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary	9
TEMPORARY REMOVAL: De-escalation in definitive surgical management for cervical cancer	9
Predictive Value Of MRI Findings For Treatment Outcomes In Early Endometrial Cancer Patients Undergoing Fertility-Sparing Treatment	8
VIOLA Project: Preventing Vulvo-Vaginal Alterations Post-Treatment In Gynecological Cancer Patients	8
The Use Of Ambient Metabolomics To Enhance The Diagnosis And Treatment Of Cervical Precancer And Cancer	8
Pelvic Exenteration: An Ultimate Option In Advanced Gynecologic Malignancies: A Single Center Experience	8
Malignant Struma Ovarii: A Series Case Report	8
Uterine Carcinosarcoma (UCS): Literature Review And Survival Analysis From A Retrospective Cohort Study	8
HPV Self-Collected Cervical Cancer Screening And Women Participation In Areas With Limited Access To Health Services In Colombia	8
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) WITH A CLOSED CO2 RECIRCULATION DEVICE IN PERITONEAL CARCINOMATOSIS FROM ADVANCED EPITHELIAL OVARIAN/TUBAL CANCER AFTER INTERVAL DEBULKING SURGERY (ID	8
Terminal T-Cell Exhaustion Is A Prognostic Biomarker Of Clinical Outcome In Homologous Recombination Deficient Ovarian Cancer	8
The Association Between Postmenopausal Spontaneous Pyometra And Gynecological Cancer – The Experience Of A Tertiary Medical Center	8
Does Size Matter? The Prognostic Role Of Lymph Node Metastasis Dimension In Endometrial Cancer Molecular Classification. A Multicentre, Retrospective Study	8
Unscheduled Bleeding In Postmenopausal Women On Hormone Replacement Therapy: A Single-Centre Analysis Of Endometrial Cancer Risk	8
Upholding standard-of-care oncological treatment in the context of pregnancy	8
Radical Colpohysterectomy: A Step-By-Step Video Guide Of A Single-Patient Case	8
Beyond The Surface: The Impact Of Mucosal Bowel Invasion On Ovarian Cancer Staging	8
Monophasic Synovial Sarcoma Of The Vulva: A Case Report And Literature Review	8
Adenocarcinoma Of Anogenital Mammary-Like Glands – A Rare Primary Vulvar Tumor	8
Gracilis Flap For Vulvar Reconstruction In 10 Steps	8
Ovarian Cancer And Severe COVID-19 Outcomes: A Matched Case-Control Study	8
Beyond Trauma: A Survivor’s Story Of Cervical Carcinosarcoma	8
The Immune-Silenced Dialogue In Endometrial Cancer Tumor Microenvironment Escape: Could The Volume Be Tuned Up By The Fetal-Maternal Immune Tolerance Cross-Talk?	8
Sentinel Lymph Node Mapping With Indocyanine Green In Endometrial Cancer	8
Morbidities After Completion Surgery In Patients Treated For Locally Advanced Cervical Adenocarcinoma	8
Introducing The Comprehensive Complication Index (CCI) To Gynecologic Oncology	8
Lymph Node And Distant Metastases In Staging And Re-Staging Of Uterine Cervical Cancer: Precise Diagnosis And Mapping Using FDG-PET/CT	8
Principles Of Laparoscopic Nerve Sparing Technique In Gynecological Surgery, Evaluation Of 290 Procedures	8
Characterization Of The Immuno-Oncological Transcriptomic Landscape Of Uterine Smooth Muscle Tumors Of Uncertain Malignancy Potential (STUMP) According To Clinical Outcome	8
Vulvar Cancer: Clinical Characteristics Of Patients In The Kasserine Region	8
Randomized Study Evaluating Optimal Dose, Efficacy And Safety Of E7386 + Lenvatinib Versus Treatment Of Physicians’ Choice In Advanced/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(	8
Survival Analysis And Comparison Between Routine And Selective Lymphadenectomy During Optimally Debulked Interval Cytoreductive Surgery In Women With Advanced Stage Carcinoma Ovary Post Neoadjuvant Ch	8
Real-World Demographics And Survival Outcomes Of Patients In England With Advanced Or Recurrent Endometrial Cancer By Mismatch Repair Status	8
Accuracy And Performance Of Different Tracers In Sentinel Lymph Node Biopsy In Endometrial Cancer: A Single-Institution Retrospective Study	8
Comprehensive Genomic Profiling (CGP) In Epithelial Ovarian Cancer: Biomarker Prevalence Across Different Histotypes	7
Single-Port Robotic Surgery Feasibility In Gynecologic Oncology: Referral Center Experience	7
Management Of Patients With Endometrial Hyperplasia: An Experience In A Tertiary Centre Over A 12-Month Period	7
Inflammation And Nutrition-Based Scores For Prognosis In Lenvatinib And Pembrolizumab Therapy For Recurrent Endometrial Cancer	7
Examining The Effect Of BCAM-AKT2 Chimeric Protein In Epithelial Ovarian Carcinoma Cells On Gene Expressions	7
Sonographically Atypical Ovarian Fibroma In Pregnancy: A Case Report And Review Of The Adnexal Malignancy Risk Assessment During Gestation	7
Relationship Between Amino Acid Transporters And Endometrial Cancer Subtypes	7
LIVER RESECTION IN CYTOREDUCTIVE SURGERY FOR OVARIAN CANCER: CASE REPORT	7
Assessing The Influence Of Chemotherapy Response Grade On Time Until Disease Progression Under Poly(ADP-Ribose) Polymerase Inhibitors: A Multicenter Analysis	7
Assessment Of Sentinel Lymph Node Biopsy Compared To Lymphadenectomy For Endometrial Cancer Staging: Experience From An ESGO Certified Center	7
A Large Retrospective Study Of Histological Outcomes In Women With Unscheduled Bleeding, With And Without Hormone Replacement Therapy	7